Found: 55
Select item for more details and to access through your institution.
Hybrid simultaneous whole-body 2-[<sup>18</sup>F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results.
- Published in:
- European Radiology, 2023, v. 33, n. 9, p. 6438, doi. 10.1007/s00330-023-09593-1
- By:
- Publication type:
- Article
Whole-body MR imaging in suspected physical child abuse: comparison with skeletal survey and bone scintigraphy findings from the PEDIMA prospective multicentre study.
- Published in:
- European Radiology, 2021, v. 31, n. 11, p. 8069, doi. 10.1007/s00330-021-07896-9
- By:
- Publication type:
- Article
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00177
- By:
- Publication type:
- Article
Improvement of radioimmunotherapy using pretargeting.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00159
- By:
- Publication type:
- Article
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5406, doi. 10.3390/ijms21155406
- By:
- Publication type:
- Article
What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2564, doi. 10.3390/ijms20102564
- By:
- Publication type:
- Article
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 445, doi. 10.3390/ijms18020445
- By:
- Publication type:
- Article
Immuno-PET for Clinical Theranostic Approaches.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 1, p. 57, doi. 10.3390/ijms18010057
- By:
- Publication type:
- Article
Tumor Immunotargeting Using Innovative Radionuclides.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 2, p. 3932, doi. 10.3390/ijms16023932
- By:
- Publication type:
- Article
From a PMT-based to a SiPM-based PET system: a study to define matched acquisition/reconstruction parameters and NEMA performance of the Biograph Vision 450.
- Published in:
- EJNMMI Physics, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40658-020-00323-w
- By:
- Publication type:
- Article
Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2532, doi. 10.3390/cancers12092532
- By:
- Publication type:
- Article
ImmunoPET in Multiple Myeloma—What? So What? Now What?
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1467, doi. 10.3390/cancers12061467
- By:
- Publication type:
- Article
FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1384, doi. 10.3390/cancers12061384
- By:
- Publication type:
- Article
Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 486, doi. 10.3390/cancers12020486
- By:
- Publication type:
- Article
Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1282, doi. 10.3390/cancers11091282
- By:
- Publication type:
- Article
BCR- ABL1 molecular remission after <sup>90</sup> Y-epratuzumab tetraxetan radioimmunotherapy in CD22<sup>+</sup> Ph<sup>+</sup> B- ALL: proof of principle.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 6, p. 552, doi. 10.1111/ejh.12183
- By:
- Publication type:
- Article
Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 6, p. 1064, doi. 10.1007/s00259-011-1741-0
- By:
- Publication type:
- Article
Prognostic impact of <sup>18</sup>F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 9, p. 1633, doi. 10.1007/s00259-010-1469-2
- By:
- Publication type:
- Article
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 7, p. 1270, doi. 10.1007/s00259-010-1417-1
- By:
- Publication type:
- Article
Analysis of <sup>18</sup>F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 11, p. 1813, doi. 10.1007/s00259-009-1183-0
- By:
- Publication type:
- Article
<sup>99m</sup>Tc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 3, p. 637, doi. 10.1007/s00259-007-0625-9
- By:
- Publication type:
- Article
Prospective comparison of two gamma probes for intraoperative detection of <sup>18</sup>F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 10, p. 1556, doi. 10.1007/s00259-007-0393-6
- By:
- Publication type:
- Article
A pretargeting system for tumor PET imaging and radioimmunotherapy.
- Published in:
- Frontiers in Pharmacology, 2015, v. 6, p. 1, doi. 10.3389/fphar.2015.00054
- By:
- Publication type:
- Article
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease.
- Published in:
- Annals of Hematology, 2006, v. 85, n. 11, p. 759, doi. 10.1007/s00277-006-0151-z
- By:
- Publication type:
- Article
Prognostic Value of <sup>18</sup>F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 156, doi. 10.2967/jnumed.123.265872
- By:
- Publication type:
- Article
Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1706, doi. 10.2967/jnumed.123.265871
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 257, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
<sup>18</sup>F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 9, p. 1380, doi. 10.2967/jnumed.117.206920
- By:
- Publication type:
- Article
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and <sup>68</sup>Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 10, p. 1505, doi. 10.2967/jnumed.116.172221
- By:
- Publication type:
- Article
Comparative Toxicity and Efficacy of Combined Radioimmunotherapy and Antiangiogenic Therapy in Carcinoembryonic Antigen-Expressing Medullary Thyroid Cancer Xenograft.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 4, p. 624, doi. 10.2967/jnumed.109.070714
- By:
- Publication type:
- Article
Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0159984
- By:
- Publication type:
- Article
The predictive power of FDG‐PET imaging with regard to immunotherapy in real‐life conditions in advanced melanoma: An exploratory study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 1, p. e61, doi. 10.1111/jdv.18501
- By:
- Publication type:
- Article
Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosis.
- Published in:
- International Journal of Computer Assisted Radiology & Surgery, 2020, v. 15, n. 1, p. 129, doi. 10.1007/s11548-019-02015-y
- By:
- Publication type:
- Article
Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 796, doi. 10.1002/hon.2965
- By:
- Publication type:
- Article
Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases.
- Published in:
- Biomedicines, 2020, v. 8, n. 12, p. 548, doi. 10.3390/biomedicines8120548
- By:
- Publication type:
- Article
Three Methods Assessing Red Marrow Dosimetry in Lymphoma Patients Treated With Radioimmunotherapy.
- Published in:
- Cancer (0008543X), 2010, v. 116, p. 1093
- By:
- Publication type:
- Article
Toxicity and Efficacy of Combined Radioimmunotherapy and Bevacizumab in a Mouse Model of Medullary Thyroid Carcinoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, p. 1053
- By:
- Publication type:
- Article
Pretargeting for imaging and therapy in oncological nuclear medicine.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2017, v. 2, n. 1, p. 1, doi. 10.1186/s41181-017-0026-8
- By:
- Publication type:
- Article
Multiple myeloma mimicking metastatic skull base paraganglioma in [<sup>68</sup> Ga]Ga-DOTATOC-PET/CT and 2-[<sup>18</sup>F]FDG-PET/CT imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 12, p. 3792, doi. 10.1007/s00259-023-06322-0
- By:
- Publication type:
- Article
Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1362, doi. 10.1007/s00259-020-05080-7
- By:
- Publication type:
- Article
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 4, p. 1005, doi. 10.1007/s00259-020-05049-6
- By:
- Publication type:
- Article
Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 1, p. 287, doi. 10.1007/s00259-020-05014-3
- By:
- Publication type:
- Article
Good clinical practice recommendations for the use of PET/CT in oncology.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 1, p. 28, doi. 10.1007/s00259-019-04553-8
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in multiple myeloma: critical insights and future directions.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor